当前位置: 首页 > 期刊 > 《医学信息》 > 2025年第13期
编号:2390302
利培酮片与富马酸喹硫平片治疗首发精神分裂症的临床疗效及对心理状态的影响
http://www.100md.com 2025年7月31日 医学信息 2025年第13期
     中图分类号:R749.3 文献标识码:A

    DOI:10.3969/j.issn.1006-1959.2025.13.034 文章编号:1006-1959(2025)13-0166-04

    Abstract:ObjectiveToomparetelinicalfcacyofispeidoetabletsndquetiapinefumaratetabletsitetreatmentoffrspisode schizophendeslousodoerabldisi schizophreniaadmitedtotepsycatricdepartentofourospitalfromJulytoJuly24weredividedintoontrolgoupndexptal group,Opatitsoupeoopsteateditaletapifuaratetabletsndepealpastreatdial rispedo visualleangli mentalsyptos)ndholocalauseeompadtnttoossultsThtotaltieatefreaetiptal group (96.00 % )washigher than that in the control group (74.00 % ) Plt; 0.05).Compared with the control group,the scores of symbol coding,semantic fluency,verbal memory,visual memoryand maze test were higher intheexperimental groupafter treatment( Plt;0.05 ),and the scores of negative symptoms,positive symptoms,general mental symptomsand HAMD scores were lower( P lt;0.05).Conclusion Compared with quetiapine fumarate tabletsspeebsoitiil psychological state of patients.It is worthy of clinical application.

    Keywords:Risperidone;Quetiapine fumarate;First schizophrenia;Psychological state ......

您现在查看是摘要页,全文长 11317 字符